Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Clinical Pharmacokinetics|July 4, 2014
Pharmacokinetics of orally administered duloxetine in children and adolescents with major depressive disorderEvelyn D Lobo, Tonya Quinlan, Apurva PrakashJournal of Diabetes and Its Complications|September 5, 2008
Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditionsJoachim F Wernicke, Apurva Prakash, Daniel K Kajdasz, et al.Psychopharmacology Bulletin|August 1, 2008
Addressing methodological issues in studying antidepressant onset efficacy using prespecified sensitivity analysesIlya Lipkovich, Craig H Mallinckrodt, Apurva Prakash, et al.The Journal of Sexual Medicine|July 14, 2007
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorderAnita Clayton, Susan Kornstein, Apurva Prakash, et al.The British Journal of Psychiatry : the Journal of Mental Science|October 3, 2002
Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorderFerenc Martenyi, Eileen B Brown, Harry Zhang, et al.The Journal of Clinical Psychiatry|April 3, 2002
Fluoxetine versus placebo in posttraumatic stress disorderFerenc Martenyi, Eileen B Brown, Harry Zhang, et al.The Journal of Pain|August 12, 2009
The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disordersJohn T Farrar, Yili L Pritchett, Michael Robinson, et al.International Journal of Breast Cancer|February 2, 2012
Evaluation of sentinel node biopsy in locally advanced breast cancer patients who become clinically node-negative after neoadjuvant chemotherapy: a preliminary studyShaji Thomas, Apurva Prakash, Vinay Goyal, et al.Clinical Pharmacokinetics|November 10, 2025
A Population Pharmacokinetic and Exposure-Response Analysis for Baricitinib in Pediatric Patients with Atopic DermatitisRodney L Decker, C Steven Ernest, David B Radtke, et al.International Clinical Psychopharmacology|November 25, 2010
Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scaleDavid V Sheehan, Kathy Harnett-Sheehan, Melissa E Spann, et al.Pageof 4